Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities.
about
Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancerPost-discharge complications after esophagectomy account for high readmission ratesMinimally Invasive Techniques and Hybrid Operations for Esophageal CancerPostoperative radiation therapy of pT2-3N0M0 esophageal carcinoma-a review.Superficial esophageal lesions detected by endoscopic ultrasound enhanced with submucosal edema.Robotic transthoracic esophagectomy.Prospective study of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma.Concurrent chemoradiotherapy with a novel fluoropyrimidine, S-1, and cisplatin for locally advanced esophageal cancer: long-term results of a phase II trial.Probing the link between oestrogen receptors and oesophageal cancer.Promising outcomes of definitive chemoradiation and cetuximab for patients with esophageal squamous cell carcinomaAccelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trialsOpen versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial.Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma.Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centreEsophageal perforation during or after conformal radiotherapy for esophageal carcinoma.Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy.Functional polymorphisms associated with disease-free survival in resected carcinoma of the esophagus.Amelanotic esophageal malignant melanoma: case report and short review of the literaturep38δ MAPK phenotype: an indicator of chemotherapeutic response in oesophageal squamous cell carcinomaClinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcomeMethyl-methanesulfonate sensitivity 19 expression is associated with metastasis and chemoradiotherapy response in esophageal cancer.Krüppel-like Factor 4 Promotes Esophageal Squamous Cell Carcinoma Differentiation by Up-regulating Keratin 13 ExpressionTransthoracic versus abdominal-transhiatal resection for treating Siewert type II/III adenocarcinoma of the esophagogastric junction: a meta-analysis.Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapyCTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma.High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma.Neoadjuvant chemoradiotherapy or chemotherapy? A comprehensive systematic review and meta-analysis of the options for neoadjuvant therapy for treating oesophageal cancer.Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis.CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1.Oncologic Long-Term Results of Robot-Assisted Minimally Invasive Thoraco-Laparoscopic Esophagectomy with Two-Field Lymphadenectomy for Esophageal Cancer.Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma.Prognosis of esophageal squamous cell carcinoma patients with preoperative radiotherapy: Comparison of different cancer staging systemsMinimally invasive resection of synchronous thoracic esophageal and gastric carcinomas followed by reconstruction: a case report.Icariin displays anticancer activity against human esophageal cancer cells via regulating endoplasmic reticulum stress-mediated apoptotic signaling.High expression of cyclooxygenase 2 is an indicator of prognosis for patients with esophageal squamous cell carcinoma after Ivor Lewis esophagectomyTrends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysisPhase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma.Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?Chemoradiotherapy for treatment of esophageal cancer in Japan: current status and perspectives.Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan.
P2860
Q24197524-8B5EBD67-0B82-46CD-92C8-704BFB581DB7Q24658449-624AFDEA-1F0B-4D65-B969-597177E1402BQ26753867-6E3E8EB5-E581-4CCE-AD32-1B93A74E0353Q30245279-D034711A-4AB9-4BC2-9419-D3C1F11D3CF5Q30445345-69A72C99-53AB-4556-BDA6-D8ECD24FEFD4Q30646993-ADEA7214-AB03-487A-8861-4BF2C4BA7C9DQ30907567-E5F77145-9BEF-4745-BECA-42781DE329CCQ33407844-EC199502-D89B-492C-B481-B96D46354182Q33702570-CE60BE0C-0031-45E9-9DB9-4714BE5B1892Q33711287-AF8903F6-478F-421A-B6F0-1135EC3DD61DQ33813067-17B1D00E-3E75-44DE-A04D-EEFCC3D10BA2Q33969006-1F248F77-EB1B-48D8-85D7-1E9FC4F5AC40Q33995199-4E2DB6DD-ECF3-44F8-A0FE-A4632929C46CQ34231941-5E9BCEA2-30F6-4A95-8351-0245516758A7Q34366540-38B21380-9D2E-40DF-9A40-D09853B428CFQ34479911-6A2B941C-84F7-44C7-B351-4E2B6A0B43F3Q34500998-62D704DB-F7C8-4276-B5D7-2B8D10EA49E9Q34569955-9E597EF4-C250-4262-AE5B-9EE5D48993A4Q34570398-59D97D16-8F87-4D88-91E2-6AAD6142AA94Q34980099-9BF927B9-ACAB-493C-BF06-29E05199E048Q35375517-68E13873-4C6A-4C83-87CA-A8CA9E1B1D80Q35861040-460AE2D2-0F33-4E28-8571-2C3B4A62C8A7Q35894848-ECCEFDD1-BBD7-4B6F-BA09-FDA48650129CQ35917802-ADCF7C1E-CF17-44FD-8B75-15A5FAD325F8Q36027105-05893118-6F43-4CF6-B9B8-1BBAAC056C7BQ36095229-70994780-4D11-48EA-B6AA-0350984D567DQ36150708-A19EBB30-FF99-477C-A140-D524BED51361Q36221479-64785D40-E8FC-4EBD-92CB-C15D518E4788Q36370199-897A1E5A-A677-4140-97E2-E1088CA94375Q36391828-841B5515-8011-48A6-B8FE-E1B22338BA23Q36413088-B027632D-3137-4CB9-914E-EC6812894B73Q36439327-31BA8AED-6DE5-427F-904B-CBAA7B3F043DQ36564158-3DD174D3-86D4-47A2-9646-F4EBE8E913B0Q36595883-54936205-A48F-4210-9A4C-53F282280154Q36840386-EED71D5E-0B51-4799-9B8C-017F1F1024EBQ36948484-1FE3544B-681E-47A5-9FF9-71F169AC95CBQ37142445-0FF627E0-8EC5-4B96-97EC-B47F99CC0F04Q37156639-269628C5-4495-4574-A375-E32C75E51AD8Q37198610-149C48A8-63DB-4701-8925-AC759EC3C7CCQ37207101-2A149FEC-5DF2-4188-BC11-9E5265C309EB
P2860
Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities.
@en
type
label
Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities.
@en
prefLabel
Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities.
@en
P2093
P1433
P1476
Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities.
@en
P2093
Christophe Mariette
Guillaume Piessen
Jean-Pierre Triboulet
P304
P356
10.1016/S1470-2045(07)70172-9
P577
2007-06-01T00:00:00Z